ANAPTYSBIO, INC Balance Sheet
ANAB / Health Care|11 years of annual SEC 10-K data (FY2015-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 11 fiscal years. All figures from audited SEC 10-K filings.
ANAPTYSBIO, INC had $364M in total assets and $37M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $238.2M | $123.1M | $36.0M | $71.3M | $495.7M | $250.5M | $171.0M | $113.6M | $81.2M | $51.2M | - |
| Current Assets | $350.3M | $431.9M | $406.8M | $447.2M | $553.9M | $396.6M | $377.7M | $434.2M | $252.7M | $58.2M | - |
| PP&E (Net) | $1.4M | $1.8M | $2.1M | $2.1M | $2.3M | $1.8M | $1.6M | $1.4M | $665.0K | $471.0K | - |
| Total Assets | $364.4M | $483.8M | $452.4M | $610.4M | $643.1M | $416.6M | $435.2M | $509.0M | $329.4M | $62.2M | - |
| Current Liabilities | $38.6M | $45.4M | $37.4M | $26.1M | $16.1M | $19.8M | $29.5M | $21.8M | $14.1M | $5.7M | - |
| Shareholders' Equity | $37.2M | $70.9M | $88.1M | $396.7M | $405.0M | $486.4M | $307.6M | $486.4M | -$35.2M | -$38.2M | -$35.2M |